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InﬂammationSepsis is the leading cause of death in critically ill patients. While myocardial dysfunction has been recognized
as a major manifestation in severe sepsis, the underlying molecular mechanisms associated with septic
cardiomyopathy remain unclear. In this study, we performed a miRNA array analysis in hearts collected from a
severe septic mouse model induced by cecal ligation and puncture (CLP). Among the 19 miRNAs that were
dys-regulated in CLP-mouse hearts, miR-223(3p) and miR-223*(5p) were most signiﬁcantly downregulated,
compared with sham-operated mouse hearts. To test whether a drop of miR-223 duplex plays any roles in
sepsis-induced cardiac dysfunction and inﬂammation, a knockout (KO) mouse model with a deletion of the
miR-223 gene locus and wild-type (WT) mice were subjected to CLP or sham surgery. We observed that
sepsis-induced cardiac dysfunction, inﬂammatory response and mortality were remarkably aggravated in
CLP-treated KO mice, compared with control WTs. Using Western-blotting and luciferase reporter assays, we
identiﬁed Sema3A, an activator of cytokine storm and a neural chemorepellent for sympathetic axons, as an
authentic target of miR-223* in the myocardium. In addition, we validated that miR-223 negatively regulated
the expression of STAT-3 and IL-6 in mouse hearts. Furthermore, injection of Sema3A protein into WT mice re-
vealed an exacerbation of sepsis-triggered inﬂammatory response and myocardial depression, compared with
control IgG1 protein-treated WT mice following CLP surgery. Taken together, these data indicate that loss of
miR-223/-223* causes an aggravation of sepsis-induced inﬂammation, myocardial dysfunction and mortality.
Our study uncovers a previously unrecognized mechanism underlying septic cardiomyopathy and thereby,
may provide a new strategy to treat sepsis.
Crown Copyright © 2014 Published by Elsevier B.V. All rights reserved.1. Introduction
Sepsis is a common complication during the course of treatment of
patients in the intensive care unit (ICU) [1]. It is initially triggered by bac-
terial infection which subsequently results in a systemic inﬂammatory
response. Over the last 3 decades, while signiﬁcant improvements have
been made in diagnostic and therapeutic approaches, sepsis is still the
leading cause of death in critically ill patients, and the 30-day mortality
rate of septic patients remains as high as 47% [1–4]. Moreover, the rate
of severe sepsis (a condition with at least one organ dysfunction) during
hospitalization almost doubled during the last decade and is remarkably
greater than previously predicted [1–4]. Recently, clinical studies haveacology and Cell Biophysics,
rt Sabin Way, Cincinnati, OH
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Published by Elsevier B.V. All rightsrecognized myocardial depression as a serious manifestation in ~40% of
septic patients, with mortality ranging from 70 to 90% in contrast with
20% in septic patients without cardiac dysfunction [5,6]. Therefore, to
reduce the mortality in septic patients, there is an urgent need to better
understand the mechanisms underlying the sepsis-caused myocardial
dysfunction and identify new therapeutic strategies.
MicroRNAs (miRs, miRNAs) are a highly conserved group of small
non-protein coding RNAs that are transcribed in the nuclei and
transported to the cytoplasm [7]. miRNAs usually regulate gene
expression by base pairing to the 3′-UTR of a mRNA with imperfect
complementary, resulting in translation inhibition, whereas perfect
base-pairing causes the degradation of target mRNA [8]. Numerous
studies have evidenced thatmiRNAs play critical roles in various cellular
functions such as cell proliferation, apoptosis, and differentiation [7,8].
They are also involved in processing many human diseases like cancer,
diabetes, obesity, viral infection and cardiovascular disorders [9–11].
In terms of sepsis, most studies have been focused on screening thereserved.
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miRNAs (i.e. miR-15a, miR-16, miR-150, miR-146a, miR-223 and
miR-574-5p) as potential biomarkers for the diagnosis of severe sepsis
[12–17]. However, fewer studies have been done to dissect possible
roles of miRNAs in the process of severe sepsis. We previously reported
that miRNAs (i.e. miR-320, miR-494 and miR-144/451) were dysregu-
lated in ischemic hearts, and observed that overexpression of miR-320
was detrimental, whereas elevation of miR-494 was protective against
ischemia/reperfusion-induced cardiac injury [18–21]. Therefore, given
that cardiac dysfunction is the major contributor to death in severe
sepsis [5,6], we hypothesized that sepsis challenge would alter the
miRNA expression proﬁle in the myocardium and consequently, up-
or down-regulation of a signiﬁcant miRNA in the heart would affect
the process of severe sepsis and mortality.
In this study, we examined myocardial miRNA expression proﬁles
after severe sepsis in a mouse model of cecal ligation and puncture
(CLP). Among the 19 miRs dysregulated in CLP-hearts, miR-223 was
the most signiﬁcantly downregulated. Surprisingly, miR-223* (miR-
223-5p) was also signiﬁcantly reduced in hearts of severely septic
mice, indicating that both strands are processed from pre-miR-223.
Most interestingly, both miR-223 and miR-223* were dramatically
increased in the mouse heart after moderate sepsis. These initial data
suggest that miR-223 duplex may be involved in sepsis-triggered
cardiac dysfunction. Currently, it has been well documented that alter-
ation of miR-223 levels is associated with several immune disorders
(i.e., rheumatoid arthritis, tuberculosis) and obesity-related adipose
tissue inﬂammation [22–26]. For example, Johnnidis et al. reported that
miR-223-null mice spontaneously developed inﬂammatory lung pathol-
ogy and displayed exaggerated lung damage upon endotoxin challenge
[26]. Consistently, a recent study by Dorhoi et al. showed that miR-223
limits neutrophil inﬂammation by reducing the production of IL-6,
MIP-1α, MIP-2, and subsequently polymorphonuclear neutrophil
(PMN) recruitment into the lung during active tuberculosis (TB) [24].
However, it remains unclear whether down-regulation of miR-223 con-
tributes to sepsis-induced myocardial depression. Furthermore, another
strand of miR-223* (-5p) is also expressed in hearts, but its function has
not caught any attentions thus far. Therefore, based on our miRNA array
data, we focused on determining the effects of pre-miR-223 deﬁciency
(both miR-223 and miR-223* are deleted) on severe sepsis-caused
cardiac dysfunction, mortality and the underlying mechanisms.
2. Material and methods
2.1. Animals
Mating pairs of miR-223 knockout mice on the background of
C57BL/6 (male: miR-223−/y and female: miR-223−/−) and wild-type
C57BL/6 mice were purchased from Jackson Laboratory (Indianapolis,
IN). The miR-223 knockout mouse model was generated by replacing
the entire endogenous 110-bp miR-223 locus on the X chromosome
with PGK-neo cassette, which was described previously [26]. The mice
were maintained and bred in the Division of Laboratory Animal Re-
sources at the University of Cincinnati Medical Center. In all studies,
7–8 week old male mice were used. All the animal experiments
conformed to the Guidelines for the Care and Use of Laboratory Animals
prepared by the National Academy of Sciences, published by
the National Institutes of Health, and approved by the University of
Cincinnati Animal Care and Use Committee.
2.2. CLP polymicrobial sepsis model
Polymicrobial sepsis was surgically induced by cecal ligation and
puncture (CLP) as previously described [27,28]. Brieﬂy, animals were
anesthetized by isoﬂurane inhalation and ventilated with room air
using a rodent ventilator. A 1- to 2-cm midline incision was made
below the diaphragm to expose the cecum. The cecum was ligated at1.0 cm from the tip with a 5–0 sterile silk suture. A single through and
through puncture was made at the middle between the ligation and
the tip of the cecum with an 18-gauge to induce a severe or 28-gauge
needle to induce a moderate septic injury (in this study, we performed
CLP with the 28-gauge needle only in Fig. 1, as indicated). After punctur-
ing, the cecum was gently squeezed to extrude a small amount
of feces and returned to the abdominal cavity. The abdominal wall
incision was closed in layers. After surgery, pre-warmed normal saline
(0.05–0.1 ml/g body weight) was administered subcutaneously. Postop-
erative pain control was managed with subcutaneous injection of
bupivacain and buprenorphine. Sham controls were exposed to the
same surgery; however, their cecumwas neither ligated nor punctured.
Formoderate and severe CLP surgery inwild-typemice, the survival rate
was monitored every 12 h for 5 days. For severe CLP surgery in WT
(miR-223+/y) and miR-223-KO (miR-223−/y) mice, the survival rate
was monitored every 2 h for 36 h using 12 animals per group. A single
peritoneal injection of recombinant mouse Sema3A protein (Life
Technologies) or IgG1 control protein (MAB002, R&D Systems) at a
dosage of 25 μg/kg body weight was administrated to miR-223+/y and
miR-223−/y mice 1 h before CLP procedure.
2.3. MiRNA microarray and quantitative RT-PCR
Total RNA was isolated from mouse hearts 6 h after CLP surgery or
sham operations, using a miRNeasy Mini kit (Qiagen). The concentra-
tion of RNAwasmeasured by a NanoDrop ND-1000 Spectrophotometer
(NanoDrop Tech., Rockland, DE). The miRNA expression proﬁling was
determined using the mouse miRNA array probes (miRCURY LNA
microRNAArray, v.10.0 from Exiqon). All microarrays and data analyses
were performed in the Genomics andMicroarray Laboratory, University
of Cincinnati Medical Center. The quantitative real time-PCR (qRT-PCR)
for validating the dysregulatedmiRNAswas performed using amiScript
PCR starter kit (#218193, Qiagen) which includes reagents for reverse
transcription, real-timePCR and a universal reverse primer. The forward
primers for real-time PCR were designed as follows: miR-223 forward,
5′-GCAGAGTGT CAG TTT GTC AAAT; miR-223* forward, 5′-GCAGAGCG
TGTATTT GACAAG; U6 RT and reverse primer, 5′-GTGCAGGGT CCGA
GGT; Forward primer, 5′-CTCGCTTCGGCAGCACA. All RT-PCR reactions,
including no-template controls and RT minus controls, were run in
triplicate in a GeneAmp PCR 9700 Thermocycler (Applied Biosystems).
The relative expression was calculated using the following equation:
relative gene expression = 2− (ΔCtsample − ΔCtcontrol).
2.4. Assessment of cardiac function in vivo and ex vivo
Cardiac functionwas assessed in vivo using transthoracic echocardi-
ography (iE33 Ultrasound System, Phillips) with a 15-MHz probe [29].
LV end-diastolic and end-systolic diameters were measured from
M-mode recordings. LV ejection fraction (EF) was calculated as: EF
(%) = [left ventricular end-diastolic dimension (LVDd)3minus left ven-
tricular end systolic dimension (LVDs)3 / (LVDd)3] × 100. LV fractional
shortening (FS) was determined as [(LVDd − LVDs) / LVDd] × 100.
All measurements were performed according to the American Society
for Echocardiology leading-edge technique standards, and averaged
over three consecutive cardiac cycles. We also measured cardiac func-
tion ex vivo in a Langendorff perfusion system, as described previously
[30]. After 10 min of perfusion, LVSP (left ventricular systolic pressure),
LVEDP (LV end-diastolic pressure), dP/dtmax and dP/dtmin (maximal and
minimal derivative of LVdeveloped pressure)were recorded for 20min.
LVDP was calculated as follows: LVDP (LV developed pressure) =
LVSP − LVEDP.
2.5. Evaluation of bacterial load in the peritoneal cavity and blood
The mice were anesthetized with pentobarbital sodium (50 mg/kg)
at 12 h after CLP or sham surgery. The peritoneal cavities were washed
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Fig. 1.miRNA expression proﬁle inmouse hearts after severe cecal ligation and puncture [CLP(s)] surgery. (A) Themortality curves of mice underwent shamoperation,moderate (m) and
severe (s) CLP-induced septic surgery. The survival rate was determined every 12 h until 5 days after surgery (n= 10 animals per group, p b 0.001). (B) A partial heat-map of the upreg-
ulated and downregulatedmiRNAs (redmeans upregulation and green represents downregulation) inmouse hearts 6 h after severe CLP (n= 4). (C)Microarray data are summarized by
volcano plot graph, which displays both fold-change and t-test criteria (log odds). (D/E) Alterations ofmiR-223 andmiR-223* expressionwere validated inCLP(s)-treatedmouse hearts by
qRT-PCR (normalized to control U6) (n=4, *, p b 0.05 vs. shams). (F/G) BothmiR-223 andmiR-223*were dramatically upregulated inmouse hearts at 6 h post-CLP (m) (n=4, *, p b 0.05
vs. shams).
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under sterile condition. Whole blood samples were collected by cardiac
puncture, using heparinized needles, and spun down at 10,000 rpm for
10 min. 100 μl of peritoneal lavage ﬂuids or blood samples was serially
diluted with sterile PBS. 50 μl of each diluted sample was placed on
trypticase soy agar plates with 5% sheep blood (BD Biosciences, San
Diego, CA) and incubated at 37 °C for 24 h. The numbers of bacterial
colonies were then counted and expressed as colony-forming units
(CFUs) per ml of blood and peritoneal lavage.
2.6. Cytokine analysis in peritoneal lavage ﬂuid, peripheral blood, and heart
tissue
At 6 h after CLP, the peritoneal exudate and serum were collected as
above. Hearts were excised, rinsed in ice-cold PBS, and immediately
homogenized in 1 ml RIPA buffer (Cell Signaling) plus 100× protease in-
hibitor cocktail (Calbiochem) using a bullet Blender (Next Advance Inc.).
Supernatants containing cytosolic proteinwere collected after centrifuga-
tion and used to detect the intracardiac cytokines. The levels of tumor
necrosis factor-α (TNF-α), interleukin 6 (IL-6) and IL-1β in the peritoneal
exudates, sera and heart homogenates were determined by commerci-
ally available ELISA kits (Thermo Scientiﬁc-Pierce), according to the
manufacturer's protocol. Cytokine levels were established by comparison
to a standard curve per the manufacturer's instructions. Myocardial
cytokine levels were normalized to the protein concentration.
2.7. Myocardial tissue myeloperoxidase activity assay
Myeloperoxidase (MPO) activity was determined as a measure of
neutrophil activity in hearts using a MPO activity ﬂuorometric assaykit (BioVision), according to the manufacturer's instructions. After
normalization for protein concentration, the MPO activity was
expressed as units per milligram of protein.
2.8. Western blot analysis
Protein samples were extracted from hearts with the procedures as
described in detail elsewhere [19]. Equal amounts of protein were sub-
jected to SDS-PAGE. A primary antibody against Sema3A (#PAB7888,
dilution 1:400, Abnova Co.), or STAT3 (SC-482, dilution 1:200 Santa
Cruz Biotechnology) was used. Monoclonal Anti-α actin (A2547, dilu-
tion 1:1000, Sigma-Aldrich) was used as an internal control. Detection
of bands was performed with the ECL system (Amersham/Pharmacia).
The density of each band was quantiﬁed by the Alpha Innotech Gel
Imaging system.
2.9. Luciferase reporter assay
For luciferase reporter experiments, four Sema3A 3′-UTR segment of
~120 bp was ampliﬁed by foot-print two-step PCR, as described previ-
ously [19], and inserted into the pMIR-REPORT™ luciferase miRNA ex-
pression reporter vector (Ambion) at sites of SpeI and HindIII. HEK293
cells were cotransfected in 12-well plates using DharmaFECT Duo
Transfection Reagent (Thermo Fisher Scientiﬁc Inc) according to the
protocol of the manufacturer, with 0.4 μg of the 3′-UTR luciferase
reporter vector and 0.08 μg of the control vector pMIR-β-gal (Ambion,
Inc.). For each well, 100 nM mimic miR-223* or mimic miR control
(Thermo Fisher Scientiﬁc Inc) was used. Cell lysates were prepared
48-h later. Luciferase activity was measured, using a Monolight
3010 luminometer (Pharmingen), and expressed as relative light
Table 2
Downregulated miRNAs in severe CLP-treated mouse hearts.
Name Average intensity Fold change
CLP(s)/sham
p value fdr
mmu-miR-223 823 −1.33 1.33E−07 6.61E−05
mmu-miR-882 150 −1.22 2.00E−07 6.61E−05
mmu-miR-706 486 −1.35 2.35E−06 3.92E−04
mmu-miR-710 162 −1.20 9.36E−06 1.03E−03
mmu-miR-883a-5p 321 −1.25 1.30E−05 1.23E−03
mmu-miR-223* 172 −1.20 4.58E−05 3.41E−03
mmu-miR-300* 201 −1.20 4.63E−05 3.40E−03
mmu-miR-142-5p 799 −1.20 7.17E−05 3.96E−03
mmu-miR-466f-3p 711 −1.17 3.58E−04 1.69E−02
mmu-miR-1196 365 −1.15 6.11E−04 2.16E−02
mmu-miR-467e* 885 −1.17 8.17E−04 2.46E−02
mmu-miR-1192 780 −1.16 9.21E−04 2.54E−02
mmu-miR-709 12,692 −1.23 2.59E−03 5.36E−02
mmu-miR-675-5p 373 −1.17 4.69E−03 7.75E−02
mmu-miR-691 1214 −1.17 7.67E−03 8.91E−02
mmu-miR-153 129 −1.3 1.24E−02 1.11E−01
mmu-miR-142-3p 1027 −1.16 3.97E−02 2.19E−01
704 X. Wang et al. / Biochimica et Biophysica Acta 1842 (2014) 701–711units using a luciferase assay kit (Promega). β-Galactosidase activity
was measured with a commercially available kit (Promega). 3′UTR
activity of each construct was expressed as the ratio of luciferase/β-
galactosidase activity. All transfections were performed in triplicate
from three independent experiments.
2.10. Statistical analysis
Data were expressed asmeans± SEM. Signiﬁcance was determined
by Student t test, and one- or two-way analysis of variance were
appropriate to determine differences within groups, with a Bonferroni
post hoc analysis. The survival rates were constructed using the
Kaplan–Meier method, and differences in mortality were compared
using the log-rank-test. A p b 0.05was considered statistically signiﬁcant.
3. Results
3.1. Both miR-223 andmiR-223* are down-regulated in mouse hearts after
severe sepsis
Clinical studies have shown that myocardial contractility is reduced
in severe sepsis which contributes to the high mortality [5,6]. Unfortu-
nately, therapeutic strategies aimed at enhancing cardiac function
with inotropes failed to improve outcomes in clinical trials [6]. This
suggests our incomplete knowledge of sepsis-caused myocardial dys-
function. To better understand cellular/molecularmechanisms involved
in the septic heart,we ﬁrst established amousemodelwithmoderate or
severe sepsis (see section Materials andmethods above). Themoderate
sepsis mice exhibited only 10% mortality at 36 h post-CLP surgery, and
just increased to 20%mortality at 72 h (Fig. 1A). Remarkably, the severe
sepsis mice showed 50% mortality at 36 h after CLP operation, and
progressed to 90% mortality at 72 h (Fig. 1A). Hereafter, the murine
model to induce severe sepsis was utilized.
To examine the role of miRNAs in sepsis-induced cardiomyopathy,
we next performed amiRNA array analysis inmouse hearts 6 h after se-
vere CLP or shamoperations. Among19dysregulatedmiRs (cut-off with
a threshold of ≥1.2 fold or ≤−1.2 fold and average intensity N100,
Tables 1 and 2), miR-223 was the most signiﬁcantly down-regulated
(Fig. 1B/C). Intriguingly, the levels of miR-223* (miR-223-5p) were
also signiﬁcantly reduced compared to shams (Fig. 1B/C). The array
data on miR-223/-223* were further validated by RT-PCR (Fig. 1D/E).
When levels of miR-223/-223* were measured in mouse hearts 6 h
after moderate CLP surgery, we surprisingly found that both were dra-
matically increased (Fig. 1F/G), suggesting a compensatory mechanism.
These results suggest that reduction of miR-223/-223* (both are
processed from pre-miR-223) in the heart may contribute to severe
sepsis-induced myocardial depression and lethality.
3.2. Knockout of miR-223/-223* exacerbates cardiac dysfunction and
increases lethality in mice with severe polymicrobial sepsis
To determine the effects of miR-223/-223* reduction on sepsis-
causedmyocardial dysfunction, we employed amousemodel previously
called miR-223 knockout (KO) mice. Actually, this model has deleted a
110-bp pre-miR-223 including both miR-223 (3p) and miR-223* (5p).
Because the miR-223 gene is localized at the X chromosome, the geno-
type of male KO mice is miR-223−/y, which we used in the following
studies. Notably, all miR-223−/y mice were healthy and showed noTable 1
Upregulated miRNAs in severe CLP-treated mouse hearts.
Name Average intensity Fold change
CLP(s)/sham
p value fdr
mmu-miR-135a 126 1.80 2.37E−06 3.92E−04
mmu-miR-215 172 1.50 6.47E−04 2.16E−02apparent cardiac morphological or pathological abnormalities (data not
shown). At 12 h after severe CLP surgery or sham operations, WT
(miR-223+/y) and KO (miR-223−/y) mouse hearts underwent functional
measurement using echocardiography (Fig. 2A–C) and by the ex vivo
Langendorff mode (Fig. 2D–F). As shown in Fig. 2A–C, absence of miR-
223/-223* did not affect myocardial function upon sham operations,
but did exaggerate sepsis-induced cardiac dysfunction, evidenced by a
signiﬁcant decrease in left ventricular ejection fraction (EF%) and frac-
tional shortening (FS%), compared to sepsis-treated WT hearts (n = 8,
p b 0.01). Similarly, the ex vivo measurement of contractile function
also exhibited the reduced rates of left ventricular contraction [LV dP/
dt(max)]and relaxation [LV dP/dt(min)] as well as developed pressure
(LVDP) to a greater degree in miR-223-null hearts than wild-type
(WT) hearts upon CLP surgery(Fig. 2D–F, n = 5, p b 0.01). In addition,
absence of miR-223 had a detrimental impact on mortality during
polymicrobial sepsis. All miR-223−/y mice died at 22 h after severe CLP
surgery, whereas 75% of WT mice remained alive (Fig. 2G, n = 12,
p b 0.001). Collectively, these data indicate that loss of miR-223/-223*
may lead to sepsis-triggered cardiac dysfunction and lethality.3.3. Absence of miR-223/223* promotes myocardial inﬂammation in mice
upon severe sepsis challenge
Given that sepsis-induced myocardial depression is largely ascribed
to the increased cardiac inﬂammation [31,32], we therefore assessed
the production of inﬂammatory cytokines [i.e. tumor necrosis factor-α
(TNF-α), IL-6 and IL-1β] inmouse hearts at 6 h post-severe CLP surgery.
The ELISA analysis results (Fig. 3A–C) showed that there was no differ-
ence in the levels of myocardial TNF-α betweenWT and KOmice upon
sham operation. However, miR-223/-223* deﬁciency signiﬁcantly exag-
gerated CLP-induced production of myocardial TNF-α, compared to
CLP-treated WT hearts (miR-223+/y) (Fig. 3A, n = 4, p b 0.01). Similar
ﬁndings were also observed in the alterations of IL-1β (Fig. 3B). Unlike
TNF-α and IL-1β, the levels of IL-6 in sham-treated KO hearts (miR-
223−/y) were increased by 2.9-fold, compared to those in WT hearts
(miR-223+/y) upon sham conditions (Fig. 3C, n= 4, p b 0.01). Remark-
ably, CLP induced an 8.3-fold increase of myocardial IL-6 in WT mice,
whereas it caused a 19.8-fold elevation of cardiac IL-6 in KO mice,
compared to sham samples, respectively (Fig. 3B, n = 5, p b 0.001). In
addition, sepsis-caused neutrophil inﬁltration into the myocardium
was assessed by a myeloperoxidase activity assay. As shown in Fig. 3D,
CLP increased myeloperoxidase activity by 1.97-fold in WT hearts and
3.26-fold in KO hearts, compared with sham controls, respectively
(n = 5, p b 0.01). Collectively, these data suggest that loss of the
miR-223 locus aggravates sepsis-triggered production of inﬂammatory
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to defects in contraction and relaxation.
3.4. Loss of duplex miR-223 increases the peritoneal and the systemic
inﬂammatory response in mice after severe CLP surgery
Next, we sought to examine whether miR-223/-223* deﬁciency
affected the peritoneal and the systemic inﬂammatory response in
mice upon septic shock. Peritoneal inﬂammation was examined by
measuring the abdominal cytokine levels in peritoneal ﬂuid at 6 h
post-CLP. The ELISA analysis results (Fig. 4A/C/E) showed that the levelsof TNF-α, IL-6 and IL-1βwere signiﬁcantly increased in bothWT andKO
mice following CLP. However, miR-223 KOmice respondedmore vigor-
ously to CLP thanWTmice, as evidenced by signiﬁcantly higher levels of
TNF-α, IL-6 and IL-1β in miR-223−/y mouse peritoneal ﬂuid (TNF-α:
135 ± 19 pg/ml; IL-6: 7.2 ± 0.7 ng/ml; IL-1β: 296 ± 49 pg/ml) than
their WT samples (TNF-α: 72.3 ± 6.2 pg/ml; IL-6: 1.8 ± 0.5 ng/ml;
IL-1β: 62 ± 15 pg/ml). Notably, while the levels of TNF-α and IL-1β
were similar between KOmice andWT controls given sham procedures
(Fig. 4A), the baseline IL-6 levels were higher in KO mice (1.1 ±
0.2 ng/ml) than WT samples (0.5 ± 0.1 ng/ml) (Fig. 4C), suggesting
that miR-223 may directly regulate IL-6 expression.
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local host response, serum cytokines were examined at 6 h following
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and peritoneal cavity plays a critical role in sepsis-induced inﬂamma-
tion and organ dysfunction [1]. To investigate whether ablation of
miR-223 locus affects bacterial load in animals subjected to sepsis by
CLP, we measured bacterial CFU in the blood and peritoneal washout
of mice at 12 h after CLP. As shown in Fig. 4G/H, miR-223-KO mice
that underwent CLP had a higher bacterial load in the blood and lavage;
in comparison, WTmice that underwent CLP had a lower bacterial load
in both compartments. In mice subjected to sham surgeries, bacteria
were not detected in either blood or lavage. These data suggest that bac-
terial clearance from the circulation and peritoneal cavity is signiﬁcantly
impaired in the global miR-223 KO mice.
3.5. MiR-223/-223* negatively regulate the STAT3 and the Sema3A
expression in mouse hearts
To elucidate the potential mechanisms underlying the miR-223-
mediated regulation of inﬂammation and cardiac dysfunction, we per-
formed a target analysis for miR-223, based on published literature
and computational predictions (TargetScan, miRDB and DIANA-
MICROT). Notably, while we identiﬁed here that both strands were
processed from pre-miR-223 (Fig. 5A), most studies to date have been
focused on miR-223(3p), and consistently validated STAT3 and IL-6 to
be authentic targets of miR-223(3p) in macrophages and myeloid cells
by several independent research groups[24,33]. Therefore, we ﬁrst
conducted ELISA and Western-blot assays to determine whether
STAT3 and IL-6 were regulated by miR-223(3p) in the myocardium. In-
deed, Fig. 3C above shows that protein levels of IL-6 were signiﬁcantly
upregulated in miR-223-KO hearts. Fig. 4C/D showing the increased
IL-6 levels in peritoneal ﬂuid and serum of miR-223-KO mice further
supports the idea that IL-6 is targeted by miR-223 in macrophages and
myeloid cells. Moreover, Western-blotting results showed that the
STAT3 protein levels were increased by 1.7-fold in miR-223-deﬁcient
hearts, compared with WTs (Fig. 5B). In addition, the protein levels of
STAT3 were elevated by 1.4-fold in severe septic hearts (Fig. 5B),
whereas it was reduced by 45% in mild septic hearts, which negatively
correlates with the downregulated and upregulated miR-223, respec-
tively (Fig. 1D/F).
We next dissected the possible targets of miR-223*(5p), which have
never gotten any attention. Interestingly, Semaphorin3A (Sema3A), a
neural chemorepellent for sympathetic axons [34], has been consistent-
ly predicted by multiple computational databases (TargetScan, miRDB
and DIANA-MICROT). Further analysis showed that miR-223* interacts
with the 3′-UTR of Sema3A at 4 different regions (Fig. 5A). Western-
blot results revealed that the Sema3A protein levels were increased by
5-fold in miR-223-KO hearts, compared with WT samples (Fig. 5B).
Supportively, the Sema3A protein levels were elevated by 1.6-fold in
severe septic hearts (Fig. 5B) where miR-223* was downregulated
(Fig. 1E); in contrast, the protein levels of Sema3A were decreased
by 67% in moderate CLP-operated mouse hearts (Fig. 5B) where miR-
223* was dramatically upregulated (Fig. 1G). Taken together, these
data indicate that miR-223* acts as a negative regulator of Sema3A
expression in the heart.
3.6. MiR-223* directly interacts with the 3′-UTR of Sema3A
While miR-223* is theoretically predicted to target the 3′-UTR of
Sema3A and Western-blot results (above) also showed their negative
relationship, whether miR-223* directly recognizes these assumed re-
gions of the Sema3A 3′-UTR remains unclear. Therefore, we generated
luciferase reporter constructs harboring a segment of these respective
binding regions (Fig. 6). These luciferase reporter constructs were
co-transfected into HEK293 cells with either miR-223* or miR control.
48 h after transfection, we performed luciferase activity assays and ob-
served that co-transfection of miR-223* strongly reduced the luciferase
activity from the reporter construct containing the Sema3A 3′-UTRfragment (51–73, 2254–2276, or 2926–2249nt) (Fig. 6). These results
indicate that the Sema3A transcript contains multiple binding motifs
which may represent a genuine target of miR-223*.
3.7. Sema3A enhances sepsis-induced inﬂammation and cardiac
dysfunction
Increased production of TNF-α, IL-6 and other pro-inﬂammatory cy-
tokines has beenwell recognized to contribute to septic cardiomyopathy
[31,32]. However, whether elevation of Sema3A induced by miR-223*
deﬁciency also plays roles in myocardial depression during sepsis re-
mains obscure. Recent evidence has shown that appropriate expression
of Sema3A is critical for heart rate control [35]. Furthermore, Sema3A
is required for sepsis-induced cytokine storm [36]. Therefore, to re-
capitulate the impact of miR-223* deﬁciency on myocardial inﬂamma-
tion and function in polymicrobial sepsis, wild-type C57BL/6 mice were
pre-administrated with either Sema3A or IgG1 control proteins as a
dosage of 25 μg/kg body weight 1 h before severe CLP procedure or
shamoperations. Six hours after CLP or sham,wemeasured inﬂammato-
ry cytokines in peritoneal lavage and heart homogenates by ELISA, and
observed that pre-treatment of Sema3A did not increase the production
of TNF-α and IL-6 in either peritoneal lavage (Fig. 7A/B) or heart homog-
enates (Fig. 7C/D) under sham conditions, compared with controls.
However, Sema3A-treated mice remarkably exhibited higher levels of
TNF-α and IL-6 in both peritoneal lavage and heart homogenates than
IgG1-treatedmice upon severe CLP (Fig. 7A–D). Accordingly, myocardial
contraction,measured by LV dP/dt (max/min), was signiﬁcantly reduced
to a greater degree in Sema3A-treated mice than control protein IgG1-
injected mice following severe CLP procedure (Fig. 7E/F). These results
may reﬂect that miR-223*-KO-mediated elevation of Sema3A contrib-
utes to sepsis-caused heart failure.
4. Discussion
Currently, the therapeutic options for septic patients with cardiovas-
cular dysfunction include prompt and adequate antibiotic therapy, early
and goal-directedﬂuid resuscitation, vasopressor and inotropic therapy,
red blood cell transfusion, and mechanical ventilation [37]. Recent
clinical and experimental studies have shown that the combination of
norepinephrine as vasopressor and dobutamine as inotropic agent is
probably the most beneﬁcial in rescuing sepsis-induced myocardial
depression [37,38]. However, none of the available strategies proven
to be effective in sepsis are designed speciﬁcally to target myocardial
dysfunction. Thus, continuing search for successful novel approaches
to the treatment of myocardial dysfunction in sepsis is urgently needed.
In this study, for the ﬁrst time, we examined themiRNA expression pro-
ﬁle in septic mouse hearts. Importantly, we report that both strands are
processed from pre-miR-223 and signiﬁcantly downregulated inmouse
hearts after severe CLP surgery, whereas they are upregulated in mouse
hearts after mild CLP operations. Given that severe CLP procedure
causes 90% mortality (Fig. 1A), we then speculated that reduction of
miR-223/-223* in the heart may be associated with sepsis-induced
myocardial depression and lethality. Indeed, miR-223/-223* knockout
hearts displayed a reduced myocardial contraction/relaxation to a
greater degree, compared to WT controls following severe CLP. Consis-
tently, a study by Johnnidis et al. observed thatmiR-223 KOmice exhib-
ited exaggerated liver, renal and muscle destruction after endotoxin
challenge [26]. In addition, recent clinical evidence demonstrates that
serum miR-223 levels are signiﬁcantly reduced in non-survival septic
patients, compared to the survivals with sepsis [15,16]. Collectively,
these data suggest that reduction of miR-223/-223* may be a major
cause of sepsis-induced multiple organ dysfunction and lethality.
There are several mechanisms that underlie miR-223/-223*-
deﬁciency-mediated septic cardiomyopathy and lethality. The ﬁrst
involves aggravation of circulating and myocardial inﬂammatory cyto-
kines in miR-223/-223* KO mice. Following sepsis in animals and
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Fig. 5. Sema3A is a target of miR-223* and STAT3 is a target of miR-223 in the mouse heart. (A) A scheme of pre-miR-223 structure and miR-223-5p (miR-223*) binding to the 3′-UTR of
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suppressive cytokines (i.e. TNF-α, IL-1β and IL-6) in serum, which,
when added in vitro to cardiomyocytes, leads to defects in contractility
[31,32,39]. TNF-α has been shown to impair contraction and relaxation
in electrically stimulated human heart strips, while repetitive subcuta-
neous injection of IL-6 into rats results in heart dilation and cardiac out-
put reduction [40]. Thus, remarkable elevation of serum TNF-α and IL-6
levels may be one of the important mechanisms of miR-223/-223*
KO-mediated heart dysfunction upon severe sepsis challenge. As for
the source of serum TNF-α and IL-6 levels aggravated in CLP-treated
miR-223/-223* KO mice, it could be largely originated from macro-
phages, leukocytes and neutrophils. Actually, a recent study byChen et al. showed that down-regulation of miR-223 promoted TLR-
triggered IL-6 and IL-1β production inmacrophages [33]. Most recently,
Dorhoi et al. reported that miR-223-KO myeloid cells released higher
levels of TNF-α and IL-6 thanWT cells upon tuberculosis (TB) encounter
[24]. In addition, we observed that cardiac tissue collected from
CLP-treated miR-223/-223* KO mice yielded higher levels of TNF-α
and IL-6 compared to WT controls, which may not only contribute to
the increased levels of circulating cytokines, but also cause defects in
myocardial contractile function.
Another cardio-depressive mechanism of miR-223-/223* deﬁciency
during sepsis may be associated with upregulation of Sema3A. In
addition to its regulatory role in sepsis-triggered cytokine storm by
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709X. Wang et al. / Biochimica et Biophysica Acta 1842 (2014) 701–711interacting with Plexin-A4 and Toll-like receptors (TLRs) [36], Sema3A
has been identiﬁed as a potent neural chemorepellent whichmay affect
the autonomic control of cardiac function [35]. Several studies have pro-
vided evidence that themore the autonomic dyscontrol, the greater the
septic death [6,41]. It has been shown that cardiac-speciﬁc overexpres-
sion of Sema3A was associated with reduced sympathetic innervation
and attenuation of the epicardial-to-endocardial innervation gradient
[35]. As a result, Sema3A-TGmice demonstrated sudden death and sus-
ceptibility to ventricular tachycardia, due to catecholamine supersensi-
tivity and prolongation of the action potential duration [35]. In the
present study, we are the ﬁrst to identify Sema3A as an authentic targetB D
0
50
100
TN
f-
(pg
/m
l)
TN
f-
(pg
/m
l)
IL
-6
 (n
g/m
l)
IL
-6
 (n
g/m
l)
Peritoneal Fluid
Sham CLP
Sham CLP
Sham
Sham
0
100
200
300
0
1
2
3
4
0
200
400
600
800
Peritoneal Fluid Heart
*
*
HeartA C 
IgG1
Sema3A
IgG1
Sema
IgG1
Sema
IgG1
Sema3A
Fig. 7. Injection of Sema3A protein re-captures the pro-inﬂammatory consequence of miR-22
mouse Sema3A protein or IgG1 control protein at a dosage of 25 μg/kg body weight 1 h befo
ﬂuid (A/B) and heart homogenates (C/D) collected 6 h after CLP were determined by ELISA. (*
protein-treated mice at 6 h post-CLP by the ex vivo Langendorff system (n = 5 mice for each sof miR-223* in the heart. Accordingly, signiﬁcantly increased protein
levels of Sema3A in miR-223/-223* KO hearts could inﬂuence sympa-
thetic innervation patterning and thereby induce cardiac dysfunction.
It is worthy to note here that bothmiR-223 andmiR-223* have been
predicted to have hundreds of targets. However, these different targets
appear to function in concert to regulate inﬂammatory response during
sepsis. For example, in addition to STAT3 and IL-6, other inﬂammation-
related targets (i.e., Mef2C, PKnox1, CXCL2, CCL3 and NLRP3) have been
conﬁrmed to be regulated by miR-223 in myeloid cells [24–26,42].
Apart from Sema3A, miR-223* is predicted to target TRAF family
member-associated NF-kappa B activator (TANK), tumor necrosis factorF
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21), tumor necrosis factor ligand superfamily member 4 (TNFsf 4), in-
terferon regulatory factor 4 (IRF4), etc. It is important to mention
here, that some of the targets (i.e. IGF1R, NFI-A and Mef2C) previously
veriﬁed in cancer cells or myeloid cells are not downregulated in
miR-223-overexpressing cardiomyocytes [43], indicating that miR-
mediated target regulation is cell-type dependent. Although it is impos-
sible to validate those targets oneby one in theheart,we cannot exclude
their potential roles in mediating miR-223-deﬁciency-induced myocar-
dial depression during sepsis. Taken together, despite numerous targets
ﬁne-tuned by miR-223/-223*, it is most likely that they work synergis-
tically against inﬂammation at multiple levels during sepsis. Therefore,
considering the septic inﬂammatory response is multifaceted and clini-
cal observations that therapies targeted at a singlemediator or pathway
[i.e. IL-6, TNF-α and activated protein C (APC)] have failed [6],
miR-223/-223* would be ideal therapeutic agents to treat sepsis. Future
studies need to clarify this issue.
Limitation of this study: we observed that the production of proin-
ﬂammatory cytokines was increased in cardiac tissue of miR-223-null
mice during sepsis, compared with controls. Given that miR-223-null
mice exhibited higher MPO activity in hearts upon CLP surgery
(Fig. 3D), we cannot differentiate cytokine productions of different cell
sources within the myocardium (i.e., cardiomyocytes, neutrophils/
macrophages, or ﬁbroblasts?). Such important issues will be addressed
in our future in vitro experiments, using cardiomyocytes, macrophages,
and neutrophils treated with Ad.pre-miR-223.
In conclusion, both miR-223 and miR-223* are downregulated
inmouse hearts following severe sepsis challenge, whereas they are up-
regulated in mild-CLP treated mouse hearts. Absence of miR-223/-223*
results in an aggravation of local and systemic inﬂammation by
targeting STAT3/IL-6 and Sema3A, leading to myocardial depression
and lethality during severe sepsis (Fig. 8). Our study provides new
evidence that elevation of miR-223/-223* could protect against sepsis-
induced organ dysfunction and lethality.
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